Marianne M. Stanford
Dartmouth, NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model.
Journal: Npj imaging
Published: September 25, 2025
Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 28, 2024
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Journal: Frontiers in cellular and infection microbiology
Published: September 20, 2022
Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy.
Journal: Oncoimmunology
Published: December 10, 2020
Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy.
Journal: Oncoimmunology
Published: September 14, 2020
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein.
Journal: Human vaccines & immunotherapeutics
Published: June 13, 2020
The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase.
Journal: Clinical Medicine Insights. Oncology
Published: May 12, 2020
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model.
Journal: Scientific reports
Published: March 18, 2020
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics.
Journal: Frontiers in immunology
Published: October 02, 2019
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge.
Journal: NPJ vaccines
Published: July 03, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
Journal: The Journal of infectious diseases
Published: December 14, 2017
Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
Journal: Journal of biomedical science
Published: October 29, 2017
Last Updated: 09/26/2026